TABLE 3

Exercise tolerance variables: comparison between patients with COPD-nonPH versus patients with COPD-PH

First author [ref.]ParticipantsSample size nVO2peak mL·Kg−1·min−1Wmax WO2 pulse mL·beat−1VE L·min−1VE/VCO2 slopeVentilatory reserve %
Studies without lung transplant candidates
 Holverda [21]COPD-nonPH1513±3.865±257.6±1.637±1036±11NR
COPD-PH1013.2±5.147±206.6±2.446±2451±23NR
 Boerrigter [18]COPD-nonPH2414±4.271±478.3±3.040.8±13NR22.9±20.7
COPD-PH239.8±2.936±266.8±2.534.7±16.3NR33.1±17.0
 Skjørten [28]COPD-nonPH7117.6±4.372±319.4±2.946±15NR9±22
COPD-PH2213.9±340±217.5±2.135±12NR−7±19
 Xiong [29]COPD-nonPH9820.4±7.2NRNRNRNRNR
COPD-PH8214.6±6.5NRNRNRNRNR
 Blanco [10]COPD-nonPH10915±368±279.4±2.546±15NR12.3±21.3
COPD-PH6510±243±206.5±2.131±11NR5.9±24.8
Studies with lung transplant candidates
 Thirapatarapong [11]COPD-nonPH6711.3±4.121±155.2±1.722±1036±817 (11–25)
COPD-PH319.5±2.515±95.0±1.718±736±713 (−2–25)
 Adir [12]COPD-nonPH209.5±2.935.7±195.5±2.126±6.444.1±7.813.5±15.0
COPD-PH249.3±2.340.4±20.45.7±2.327.9±13.137.6±7.319.4±28.3

Data are presented as mean±sd or median (interquartile range), unless otherwise stated. VO2peak: peak oxygen uptake; Wmax: maximum workload; VE: minute ventilation; VE/VCO2: minute ventilation/carbon dioxide production; PH: pulmonary hypertension; NR: not reported.